Pathology review impacts clinical management of patients with T1‒T2 bladder cancer

Abstract

Review by genitourinary pathologist remains important, as it defines more clearly the tumour risk category and influences the management of T1<i>-</i>T2 bladder cancer patients. A complete initial pathological report has the potential to further decrease the discrepancy between initial and review reports.